Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pyxis Oncology Inc (NQ: PYXS ) 3.770 +0.020 (+0.53%) Streaming Delayed Price Updated: 12:21 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Pyxis Oncology Inc Pyxis Oncology to Participate in Two Upcoming Investor Conferences August 29, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 August 14, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference July 29, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 28, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger June 10, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference May 30, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 14, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference May 09, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 28, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights March 27, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 March 21, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA March 13, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 March 07, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting March 05, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Announces $50 Million Private Placement February 27, 2024 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 29, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer November 28, 2023 Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates (ADCs) and other oncology modalities From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update November 07, 2023 From Pyxis Oncology Via GlobeNewswire New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review October 13, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety NASDAQ:PYXS Investor Notice: Investigation over Possible Securities Laws Violations by Pyxis Oncology, Inc. October 05, 2023 San Diego, CA -- (SBWIRE) -- 10/05/2023 -- Pyxis Oncology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 September 27, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Participate in Two Upcoming Investment Conferences August 31, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Successfully Completes Acquisition of Apexigen August 23, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update August 11, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference August 01, 2023 From Pyxis Oncology Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.